153 related articles for article (PubMed ID: 34820244)
1. Clinical Predictors of Locally Advanced Pathology in Esophageal Adenocarcinoma.
Gomez Cifuentes JD; Haider M; Sanaka MR; Kumar P; Bena J; McMichael J; Sohal DP; Raja S; Murthy S; Thota PN
Cureus; 2021 Oct; 13(10):e18991. PubMed ID: 34820244
[TBL] [Abstract][Full Text] [Related]
2. Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma.
Thota PN; Alkhayyat M; Gomez Cifuentes JD; Haider M; Bena J; McMichael J; Sohal DP; Raja S; Sanaka MR
J Clin Gastroenterol; 2022 Feb; 56(2):125-132. PubMed ID: 33405434
[TBL] [Abstract][Full Text] [Related]
3. Routine staging with endoscopic ultrasound in patients with obstructing esophageal cancer and dysphagia rarely impacts treatment decisions.
Mansfield SA; El-Dika S; Krishna SG; Perry KA; Walker JP
Surg Endosc; 2017 Aug; 31(8):3227-3233. PubMed ID: 27864719
[TBL] [Abstract][Full Text] [Related]
4. Role of EUS in patients with suspected Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy.
Bartel MJ; Wallace TM; Gomez-Esquivel RD; Raimondo M; Wolfsen HC; Woodward TA; Wallace MB
Gastrointest Endosc; 2017 Aug; 86(2):292-298. PubMed ID: 27889544
[TBL] [Abstract][Full Text] [Related]
5. Exploring diagnostic and therapeutic implications of endoscopic mucosal resection in EUS-staged T2 esophageal adenocarcinoma.
Gotink AW; Spaander MCW; Doukas M; Tang TJ; Didden P; Wijnhoven BPL; Bruno MJ; Koch AD
Endoscopy; 2017 Oct; 49(10):941-948. PubMed ID: 28637063
[No Abstract] [Full Text] [Related]
6. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?
Luu C; Amaral M; Klapman J; Harris C; Almhanna K; Hoffe S; Frakes J; Pimiento JM; Fontaine JP
World J Gastroenterol; 2017 Dec; 23(46):8193-8199. PubMed ID: 29290655
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of endoscopic submucosal dissection in esophageal adenocarcinoma staged T1bN0 by endoscopic ultrasound in non-surgical patients.
Parikh MP; Thota PN; Raja S; Murthy S; Ahmad U; Gupta NM; Sanaka MR
J Gastrointest Oncol; 2019 Apr; 10(2):362-366. PubMed ID: 31032107
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
[TBL] [Abstract][Full Text] [Related]
10. Locally advanced esophageal carcinoma: is there still a role of surgery alone without neoadjuvant treatment?
Reeh M; Nentwich MF; Asani S; Uzunoglu FG; Bockhorn M; Sauter G; Rösch T; Izbicki JR; Bogoevski D
J Gastrointest Surg; 2015 Apr; 19(4):587-93. PubMed ID: 25652343
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: Impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy.
DeWitt J; Kesler K; Brooks JA; LeBlanc J; McHenry L; McGreevy K; Sherman S
Dis Esophagus; 2005; 18(1):21-7. PubMed ID: 15773837
[TBL] [Abstract][Full Text] [Related]
12. Influence of treatment modality in outcomes for different stages of resectable esophageal adenocarcinomas.
Allan BJ; Pedroso F; Gennis ER; Livingstone AS; Montero A; Lally B; Ardalan B; Koniaris LG; Solomon NL; Franceschi D
Ann Surg Oncol; 2013 May; 20(5):1660-7. PubMed ID: 23456314
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer.
Ribeiro A; Franceschi D; Parra J; Livingstone A; Lima M; Hamilton-Nelson K; Ardalan B
Am J Gastroenterol; 2006 Jun; 101(6):1216-21. PubMed ID: 16771940
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic ultrasound for preoperative staging of esophageal carcinoma.
Zhang X; Watson DI; Lally C; Bessell JR
Surg Endosc; 2005 Dec; 19(12):1618-21. PubMed ID: 16211436
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic ultrasound errors in esophageal cancer.
Zuccaro G; Rice TW; Vargo JJ; Goldblum JR; Rybicki LA; Dumot JA; Adelstein DJ; Trolli PA; Blackstone EH
Am J Gastroenterol; 2005 Mar; 100(3):601-6. PubMed ID: 15743358
[TBL] [Abstract][Full Text] [Related]
16. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
[TBL] [Abstract][Full Text] [Related]
17. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
18. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN
JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198
[TBL] [Abstract][Full Text] [Related]
19. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.
Thota PN; Sada A; Sanaka MR; Jang S; Lopez R; Goldblum JR; Liu X; Dumot JA; Vargo J; Zuccarro G
Surg Endosc; 2017 Mar; 31(3):1336-1341. PubMed ID: 27444824
[TBL] [Abstract][Full Text] [Related]
20. Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.
Borggreve AS; Mook S; Verheij M; Mul VEM; Bergman JJ; Bartels-Rutten A; Ter Beek LC; Beets-Tan RGH; Bennink RJ; van Berge Henegouwen MI; Brosens LAA; Defize IL; van Dieren JM; Dijkstra H; van Hillegersberg R; Hulshof MC; van Laarhoven HWM; Lam MGEH; van Lier ALHMW; Muijs CT; Nagengast WB; Nederveen AJ; Noordzij W; Plukker JTM; van Rossum PSN; Ruurda JP; van Sandick JW; Weusten BLAM; Voncken FEM; Yakar D; Meijer GJ;
BMC Cancer; 2018 Oct; 18(1):1006. PubMed ID: 30342494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
